The global surgical planning software market size is accounted at USD 123.07 million in 2025 and is forecasted to hit around USD 219.50 million by 2034, representing a CAGR of 6.64% from 2025 to 2034. The North America market size was estimated at USD 49.63 million in 2024 and is expanding at a CAGR of 6.76% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Surgical Planning Software Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Surgical Planning Software Market Revenue and Volume, by Delivery
8.1.1 Cloud-based
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. On-premises
8.1.2.1. Market Revenue and Volume Forecast
9.1. Surgical Planning Software Market Revenue and Volume, by Application
9.1.1. Orthopedic Surgery
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Neurosurgery
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Dental and Orthodontics
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Others (cardiology, gastroenterology, gynecology)
9.1.4.1. Market Revenue and Volume Forecast
10.1. Surgical Planning Software Market Revenue and Volume, by End Use
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Delivery
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End Use
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Delivery
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End Use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Delivery
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End Use
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Delivery
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End Use
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Delivery
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End Use
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Delivery
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End Use
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Delivery
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End Use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Delivery
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End Use
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Delivery
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End Use
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Delivery
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End Use
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Delivery
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End Use
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Delivery
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End Use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Delivery
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End Use
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Delivery
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End Use
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Delivery
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End Use
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Delivery
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End Use
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Delivery
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End Use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Delivery
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End Use
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Delivery
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End Use
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Delivery
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End Use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Delivery
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End Use
12.1. Stryker
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Zimmer Biomet.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Materialise
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Brainlab AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. 3D Systems Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. mediCAD Hectec GmbH
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. CANON MEDICAL SYSTEMS USA, INC.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. General Electric Company
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Renishaw Plc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample